+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neoantigen"

Personalized Immunotherapy for Tumor Diseases and Beyond - Product Thumbnail Image

Personalized Immunotherapy for Tumor Diseases and Beyond

  • Book
  • November 2020
From
Drug Delivery in Cancer - Technologies, Markets & Companies - Product Thumbnail Image

Drug Delivery in Cancer - Technologies, Markets & Companies

  • Report
  • November 2021
  • 747 Pages
  • Global
From
Immune Checkpoint Inhibitors Market By Type, By Application: Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Thumbnail Image

Immune Checkpoint Inhibitors Market By Type, By Application: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • December 2023
  • 248 Pages
  • Global
From
Cell-based Cancer Immunotherapy. Methods in Cell Biology Volume 183 - Product Thumbnail Image

Cell-based Cancer Immunotherapy. Methods in Cell Biology Volume 183

  • Book
  • March 2024
Tumor Immunology and Immunotherapy - Integrated Methods Part A - Product Thumbnail Image

Tumor Immunology and Immunotherapy - Integrated Methods Part A

  • Book
  • March 2020
Nanovaccinology as Targeted Therapeutics. Edition No. 1 - Product Thumbnail Image

Nanovaccinology as Targeted Therapeutics. Edition No. 1

  • Book
  • August 2022
  • 352 Pages
Precision Medicine in Oncology. Edition No. 1 - Product Thumbnail Image

Precision Medicine in Oncology. Edition No. 1

  • Book
  • October 2020
  • 288 Pages
Loading Indicator

The Neoantigen market is a subset of the Genomics market that focuses on the identification and development of neoantigens for use in cancer immunotherapy. Neoantigens are proteins that are produced by tumor cells and are recognized by the immune system as foreign, triggering an immune response. By targeting these neoantigens, cancer immunotherapy can be used to treat cancer. Companies in the Neoantigen market are focused on developing technologies to identify and develop neoantigens for use in cancer immunotherapy. Companies in the Neoantigen market include Adaptive Biotechnologies, I-Mab, Neoantigen Therapeutics, NeoVax, and OncoImmune. Show Less Read more